Walleye Trading’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-15,000
| Closed | -$1.19M | – | 4402 |
|
|
2025
Q4 | $1.19M | Buy |
15,000
+8,800
| +142% | +$663K | ﹤0.01% | 2251 |
|
|
2025
Q3 | $406K | Sell |
6,200
-3,600
| -37% | -$176K | ﹤0.01% | 2886 |
|
|
2025
Q2 | $387K | Sell |
9,800
-600
| -6% | -$19.6K | ﹤0.01% | 2819 |
|
|
2025
Q1 | $314K | Sell |
10,400
-4,400
| -30% | -$144K | ﹤0.01% | 2807 |
|
|
2024
Q4 | $517K | Buy |
14,800
+3,800
| +35% | +$142K | ﹤0.01% | 2617 |
|
|
2024
Q3 | $441K | Sell |
11,000
-17,700
| -62% | -$824K | ﹤0.01% | 2593 |
|
|
2024
Q2 | $1.37M | Sell |
28,700
-14,600
| -34% | -$599K | ﹤0.01% | 1849 |
|
|
2024
Q1 | $1.88M | Buy |
43,300
+41,300
| +2,065% | +$1.97M | ﹤0.01% | 1765 |
|
|
2023
Q4 | $101K | Sell |
2,000
-700
| -26% | -$33.5K | ﹤0.01% | 4143 |
|
|
2023
Q3 | $122K | Sell |
2,700
-21,800
| -89% | -$899K | ﹤0.01% | 3873 |
|
|
2023
Q2 | $1.01M | Sell |
24,500
-1,500
| -6% | -$57.6K | ﹤0.01% | 2170 |
|
|
2023
Q1 | $929K | Buy |
26,000
+10,700
| +70% | +$402K | ﹤0.01% | 2263 |
|
|
2022
Q4 | $578K | Buy |
15,300
+400
| +3% | +$16.8K | ﹤0.01% | 2686 |
|
|
2022
Q3 | $659K | Sell |
14,900
-6,800
| -31% | -$287K | ﹤0.01% | 2648 |
|
|
2022
Q2 | $803K | Buy |
+21,700
| New | +$818K | ﹤0.01% | 2442 |
|
|
2022
Q1 | – | Sell |
-12,500
| Closed | -$380K | – | 5572 |
|
|
2021
Q4 | $380K | Sell |
12,500
-9,300
| -43% | -$293K | ﹤0.01% | 3218 |
|
|
2021
Q3 | $731K | Buy |
21,800
+13,000
| +148% | +$490K | ﹤0.01% | 2547 |
|
|
2021
Q2 | $351K | Sell |
8,800
-19,600
| -69% | -$768K | ﹤0.01% | 3334 |
|
|
2021
Q1 | $1.28M | Buy |
28,400
+22,600
| +390% | +$1.26M | 0.01% | 1705 |
|
|
2020
Q4 | $328K | Sell |
5,800
-4,300
| -43% | -$214K | ﹤0.01% | 3053 |
|
|
2020
Q3 | $479K | Sell |
10,100
-1,200
| -11% | -$66.7K | ﹤0.01% | 2276 |
|
|
2020
Q2 | $666K | Sell |
11,300
-5,200
| -32% | -$289K | ﹤0.01% | 2016 |
|
|
2020
Q1 | $780K | Buy |
16,500
+16,400
| +16,400% | +$914K | 0.01% | 1490 |
|
|
2019
Q4 | $6K | Sell |
100
-5,300
| -98% | -$316K | ﹤0.01% | 4100 |
|
|
2019
Q3 | $324K | Sell |
5,400
-3,100
| -36% | -$202K | ﹤0.01% | 2524 |
|
|
2019
Q2 | $546K | Buy |
8,500
+4,600
| +118% | +$325K | ﹤0.01% | 2119 |
|
|
2019
Q1 | $317K | Sell |
3,900
-15,200
| -80% | -$981K | ﹤0.01% | 2663 |
|
|
2018
Q4 | $1.03M | Sell |
19,100
-34,900
| -65% | -$1.78M | 0.01% | 1687 |
|
|
2018
Q3 | $2.79M | Buy |
54,000
+21,300
| +65% | +$1M | 0.01% | 1041 |
|
|
2018
Q2 | $1.36M | Buy |
+32,700
| New | +$1.45M | 0.01% | 1755 |
|
Other funds holding IONS
VPM
VCM
Walleye Trading's IONS Position: Q2 2025 in Review
Walleye Trading sold out of Ionis Pharmaceuticals (IONS) in Q2 2025, closing a stake of 9,361 shares — an estimated $306K sold.
Walleye Trading first reported a position in IONS in Q4 2015 and held it in 20 quarters. The position peaked at $1.58M in Q1 2020. 362 funds tracked by Wall St. Rank hold IONS as of Q2 2025.
- Walleye Trading reported no remaining Ionis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Walleye Trading sold 9,361 Ionis Pharmaceuticals shares in Q2 2025, an estimated $306K.
- Walleye Trading first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 20 quarters.
- Walleye Trading's Ionis Pharmaceuticals position peaked at $1.58M in Q1 2020.
- 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2025.
Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.